Table 1. Patient’s characteristics.
Treatments |
Duration (months) |
Dosage |
Initial result |
Side effects |
Outcome |
Acitrecin |
6 |
25 mg /day |
Improvement |
1. Increase of cholesterol levels 2. Acute paronychia 3. Severe cheilitis 4. Pruritus 5. Arhralgia, myalgia 6. Alopecia (eyebrows, scalp) |
Discontinuation |
Methotrexate |
6 |
25 mg / week |
Unresponsive |
1. 2nd development of inverse psoriasis 2. Increase of alanine aminotransferase levels |
Discontinuation |
Cyclosporin |
11 |
200 mg /day |
Improvement |
1. Relapse during withdrawl (at 1.5 mg/kgr) |
Discontinuation |
Efalizumab |
8 |
1.0 mg/kg/week |
Improvement |
1. Severe hypetrichosis because of increase of free testosterone levels 2. Exacerbation after 2 months of therapy |
Discontinuation |
Etanercept |
2 |
50 mg / week |
Unresponsive |
1. 1st development of inverse psoriasis 2. Purulent infection of the auricular duct |
Discontinuation |
Infliximab |
3 |
5 mg/kg every 2 months |
Improvement |
1. Pruritus of soles 2. Exacerbation after the 3rd injection 3. Exacerbation of psoriasis affecting scalp (new location) |
Discontinuation |
Adalimumab |
3 |
40 mg every 2 weeks |
Unresponsive |
1. Exacerbation of psoriasis affecting palms (new location) |
Discontinuation |
Ustekinumab |
14 |
45 mg every 3 months |
Improvement |
1. Progressive but delayed improvement |
Clearance after the 5th injection |